Cian Healthcare Ltd

Cian Healthcare Ltd

₹ 21.0 -4.02%
12 Apr 4:01 p.m.
About

Incorporated in 2003, Cian Healthcare Ltd is engaged in manufacturing and marketing of pharmaceutical products.[1]

Key Points

Business Overview:[1][2]
CHI is a fully integrated pharmaceutical company dealing in gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.

  • Market Cap 52.5 Cr.
  • Current Price 21.0
  • High / Low 41.1 / 16.0
  • Stock P/E 750
  • Book Value 22.4
  • Dividend Yield 0.00 %
  • ROCE 6.91 %
  • ROE 3.44 %
  • Face Value 10.0

Pros

  • Stock is trading at 1.02 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -2.24%
  • Company has a low return on equity of -2.01% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023
29.41 27.68 38.89 34.84 46.91 30.96 37.88 30.71 32.61
26.43 23.48 33.91 28.03 43.57 30.06 32.40 23.82 28.13
Operating Profit 2.98 4.20 4.98 6.81 3.34 0.90 5.48 6.89 4.48
OPM % 10.13% 15.17% 12.81% 19.55% 7.12% 2.91% 14.47% 22.44% 13.74%
0.19 0.67 -0.06 0.13 0.12 0.35 0.54 0.20 0.25
Interest 3.59 3.53 3.56 4.16 3.24 3.20 3.13 2.56 3.08
Depreciation 1.61 2.84 2.24 1.22 1.79 2.48 2.71 2.72 2.72
Profit before tax -2.03 -1.50 -0.88 1.56 -1.57 -4.43 0.18 1.81 -1.07
Tax % 0.00% -17.33% -22.73% 27.56% -7.01% 13.09% -166.67% 13.81% -37.38%
-2.02 -1.76 -1.08 1.13 -1.68 -3.85 0.48 1.55 -1.48
EPS in Rs -0.86 -0.75 -0.46 0.48 -0.72 -1.54 0.19 0.62 -0.59
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
57.09 73.73 77.87 68.59 63.32
49.74 61.74 73.52 55.60 51.95
Operating Profit 7.35 11.99 4.35 12.99 11.37
OPM % 12.87% 16.26% 5.59% 18.94% 17.96%
0.79 0.07 0.47 0.73 0.45
Interest 7.22 7.92 6.55 6.30 5.64
Depreciation 4.45 3.45 4.27 5.43 5.44
Profit before tax -3.53 0.69 -6.00 1.99 0.74
Tax % -7.37% 91.30% 7.83% -2.01%
-3.79 0.05 -5.53 2.03 0.07
EPS in Rs -1.62 0.02 -2.21 0.81 0.03
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 6%
TTM: -8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 36%
TTM: 102%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 25%
1 Year: -14%
Return on Equity
10 Years: %
5 Years: %
3 Years: -2%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 23.36 23.36 25.00 25.00 25.00
Reserves 34.83 34.88 30.46 32.49 31.01
72.94 70.73 63.05 60.81 58.10
25.41 28.28 47.42 42.18 49.01
Total Liabilities 156.54 157.25 165.93 160.48 163.12
39.43 36.54 49.58 44.59 41.96
CWIP 25.03 25.93 13.00 13.89 14.30
Investments 4.89 4.89 4.89 4.89 4.89
87.19 89.89 98.46 97.11 101.97
Total Assets 156.54 157.25 165.93 160.48 163.12

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
-7.31 5.93 8.58 4.84
-27.44 2.71 1.40 2.55
35.78 -9.78 -10.96 -7.41
Net Cash Flow 1.03 -1.13 -0.98 -0.01

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 127.80 93.56 125.24 139.58
Inventory Days 267.18 312.78 378.26 333.59
Days Payable 220.03 209.37 341.08 246.73
Cash Conversion Cycle 174.95 196.98 162.43 226.44
Working Capital Days 150.88 179.95 155.10 207.91
ROCE % 6.78% 0.50% 6.91%

Shareholding Pattern

Numbers in percentages

14 Recently
Sep 2019Mar 2020Sep 2020Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023
70.89% 70.89% 70.89% 70.89% 70.89% 66.26% 66.26% 66.26% 66.26% 51.85% 49.62%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.79% 0.00% 0.00%
29.11% 29.11% 29.11% 29.11% 29.11% 33.74% 33.74% 33.75% 32.96% 48.16% 50.39%
No. of Shareholders 317326352361385396392424418454672

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents